/Live Attenuated Leishmania Parasite Vaccines With Enhanced Safety Characteristics
Abstract

Disclosed herein are modified Leishmania species and compositions thereof, such as live, attenuated organisms, immunogenic compositions, vaccines, and pharmaceutical compositions. Further disclosed are methods related to the modified Leishmania species, such as methods of production and methods of use.

Full Text

What is claimed is:

Disclosed herein are modified Leishmania species and compositions thereof, such as live, attenuated organisms, immunogenic compositions, vaccines, and pharmaceutical compositions. Further disclosed are methods related to the modified Leishmania species, such as methods of production and methods of use.
Timeline
Filed
05/26/2026
Published
09/17/2026
Granted
Not Available
IPC Codes(5)
A61K 39/008:Leishmania antigens
A61K 39/00:Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53)
A61P 33/02:Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis